Biotech

Stem Cell Therapeutics Completes $33 Million Private Placement

TORONTO, ONTARIO: ...

Theratechnologies Regains U.S. Marketing Rights to EGRIFTA(R)

MONTREAL, CANADA: ...

Corcept Therapeutics Announces Oncology Development Program

SAN ANTONIO, TX: Five of Eight Patients With Relapsed, Metastatic Triple-Negative Breast Cancer (TNBC) Experienced a Partial or Complete Response With Mifepristone and Chemotherapy Combination According to Data Presen ...

Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal Model of Aplastic Anemia

SAN DIEGO, CA: Ongoing Experiments Support Planned Response to FDA Questions for IND #15376 ...

ProMetic Announces Operational Launch of its Plasma Purification Facility

LAVAL, QUEBEC: - First production run at commercial scale performed - Critical step leading to manufacturing of orphan drugs completed ...

Lorus Therapeutics Completes $7,001,500 Prospectus Offering of Common Shares

TORONTO, ONTARIO: ...

Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial

MELBOURNE, AUSTRALIA: 83% of Patients Completing Treatment in IMAGINE Trial Opt to Join Extension ...

Boston Therapeutics Appoints Three to Management Positions

MANCHESTER, NH: Company Appoints Edward Shea as VP Business Development, Tina M. Gagnon as Consulting Director of Finance, and Yael T. Bobruff, Ph.D. as Clinical Affairs Manager ...

Aeolus Files Application for New Patent on AEOL 10150

MISSION VIEJO, CA: ...

Lorus Therapeutics to Present at Oppenheimer & Co. 24th Annual Healthcare Conference

TORONTO, ONTARIO: ...